Posted on February 9, 2016 by Sitemaster
Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: agonist, antagonist, cost-effectiveness, LHRH, lycopene, proton beam, PSA density, side effect, testosterone, tomato | 3 Comments »
Posted on December 11, 2009 by Sitemaster
Today’s news reports comment on:
- Prostate cancer incidence in Asia vs. the West
- PSA density as a risk factor for upgrading after surgery
- The mechanisms of progression of CRPC … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Asia, CRPC, incidence, progression, PSA density, upgrading | Leave a comment »
Posted on November 29, 2008 by Sitemaster
We have separately addressed a report on 10-year outcome data following (non-robotic) laparoscopic radical prostatectomy for localized prostate cancer. In today’s other reports we have addressed:
- The potential of annexin A3 as a marker for early diagnosis of prostate cancer
- The ability of PSAV and PSAD to predict risk for prostate cancer in men with one or more negative prostate biopsies
- Estrogens, estrogen receptors, and prostate cancer development and progression
- Differences between clinical and pathological Gleason scores and the impact on outcomes following surgery … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: annexin, estogen, Gleason score, marker, PSA density, PSA velocity, receptor | Leave a comment »